NFE2L2 and obesity due to melanocortin 4 receptor deficiency: SFN treatment resulted in body weight loss and improvement in obesity, where it was reported that NRF2-dependent antioxidant genes were upregulated in the skeletal muscle and that fatty acid synthesis genes were downregulated in the liver, BAT, and eWAT (6).